Masami Miki

5PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
Hypercoagulability Predicts Survival and Reflects NET-Associated Thromboinflammation in Advanced Pancreatic Cancer.

|Sep 09, 2022
Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic Cancer: A Multicenter, Prospective Observational Study.

Masami Miki, Nao Fujimori, Keijiro Ueda

|Nov 24, 2021
Loss of adipose tissue or skeletal muscle during first-line gemcitabine/nab-paclitaxel therapy is associated with worse survival after second-line therapy of advanced pancreatic cancer.

Masami Miki, Lingaku Lee, Terumasa Hisano

|May 27, 2019
CLEC3A, MMP7, and LCN2 as novel markers for predicting recurrence in resected G1 and G2 pancreatic neuroendocrine tumors.

Masami Miki, Takamasa Oono, Nao Fujimori

|Feb 01, 2019
Relapse patterns and predictors of IgG4-related diseases involved with autoimmune pancreatitis: A single-center retrospective study of 115 patients.

Masami Miki, Nao Fujimori, Takamasa Oono

Pageof 1

Frequent Collaborators

1 joint publications

Nao Fujimori

1 joint publications

Keijiro Ueda

1 joint publications

Lingaku Lee

1 joint publications

Terumasa Hisano